Literature DB >> 21840355

Squalenoylation: a generic platform for nanoparticular drug delivery.

Didier Desmaële1, Ruxandra Gref, Patrick Couvreur.   

Abstract

Squalene is a triterpene widely distributed in nature that is an intermediate in the cholesterol biosynthesis pathway. The remarkable dynamic folded conformation of squalene has been used to chemically conjugate this lipid with various therapeutic molecules to construct nanoassemblies of 100-300 nm. In this review, we discuss the new concept of "squalenoylation" through application to anticancer (i.e. gemcitabine, paclitaxel, cisplatin etc.…) or antiviral (ddI, ddC) compounds. In a lego-type approach, it is also possible to construct multifunctional nanoparticles endowed with additional imaging functionalities (i.e. "Nanotheragnostics"). This new nanotechnology platform is expected to have important applications in pharmacology.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840355     DOI: 10.1016/j.jconrel.2011.07.038

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  High-level recombinant production of squalene using selected Saccharomyces cerevisiae strains.

Authors:  Jong Yun Han; Sung Hwa Seo; Jae Myeong Song; Hongweon Lee; Eui-Sung Choi
Journal:  J Ind Microbiol Biotechnol       Date:  2018-02-02       Impact factor: 3.346

Review 2.  One-component nanomedicine.

Authors:  Hao Su; Jin Mo Koo; Honggang Cui
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

3.  Gemcitabine-retinoid prodrug loaded nanoparticles display in vitro antitumor efficacy towards drug-resilient human PANC-1 pancreatic cancer cells.

Authors:  Hamilton Kakwere; Elizabeth S Ingham; Spencer K Tumbale; Katherine W Ferrara
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-07-04       Impact factor: 7.328

Review 4.  Nanotechnology and the treatment of HIV infection.

Authors:  Raveen Parboosing; Glenn E M Maguire; Patrick Govender; Hendrik G Kruger
Journal:  Viruses       Date:  2012-04-10       Impact factor: 5.048

5.  Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.

Authors:  Carlos Rodríguez-Nogales; Didier Desmaële; Víctor Sebastián; Patrick Couvreur; María J Blanco-Prieto
Journal:  ChemMedChem       Date:  2021-10-22       Impact factor: 3.540

6.  Effects of siRNA on RET/PTC3 junction oncogene in papillary thyroid carcinoma: from molecular and cellular studies to preclinical investigations.

Authors:  Hafiz Muhammad Ali; Giorgia Urbinati; Hubert Chapuis; Didier Desmaele; Jean-Rémi Bertrand; Patrick Couvreur; Liliane Massaad-Massade
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 7.  Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.

Authors:  Sabrina Valetti; Simona Mura; Barbara Stella; Patrick Couvreur
Journal:  J Nanobiotechnology       Date:  2013-12-10       Impact factor: 10.435

Review 8.  Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking.

Authors:  João Conniot; Joana M Silva; Joana G Fernandes; Liana C Silva; Rogério Gaspar; Steve Brocchini; Helena F Florindo; Teresa S Barata
Journal:  Front Chem       Date:  2014-11-26       Impact factor: 5.221

9.  Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.

Authors:  Andrei Maksimenko; Mouad Alami; Fatima Zouhiri; Jean-Daniel Brion; Alain Pruvost; Julie Mougin; Abdallah Hamze; Tanguy Boissenot; Olivier Provot; Didier Desmaële; Patrick Couvreur
Journal:  ACS Nano       Date:  2014-02-26       Impact factor: 15.881

10.  Novel self assembling nanoparticles for the oral administration of fondaparinux: synthesis, characterization and in vivo evaluation.

Authors:  Bettina Ralay-Ranaivo; Didier Desmaële; Elsa P Bianchini; Elise Lepeltier; Claudie Bourgaux; Delphine Borgel; Thierry Pouget; Jean François Tranchant; Patrick Couvreur; Ruxandra Gref
Journal:  J Control Release       Date:  2014-08-13       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.